Compulsory licensing for expensive medicines
KCE Reports 356C (2022)
How to refer to this report
Van Zimmeren Esther, Minssen Timo, Paemen Liesbet, Van Dyck Walter, Luyten Jeroen, Janssens Rosanne, Barbier Liese, Simoens Steven, Pouppez Céline, Cleemput Irina, Vinck Imgard. Compulsory licensing for expensive medicines. Health Services Research (HSR). Brussels. Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. DOI: 10.57598/R356C.
Other KCE reports on
Contact Information
ANNUAL REPORT
